Mechanisms underlying resistance of pancreatic islets from ALR/Lt mice to cytokine-induced destruction

Journal of Immunology

Volumn 175, Issue 2, 2005, Pages 1248-1256

  Mathews, Clayton E ^a   Suarez Pinzon, Wilma L ^b   Baust, Jeffrey J ^a   Strynadka, Ken ^b   Leiter, Edward H ^c   Rabinovitch, Alex ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ANTIGEN; CELL PROTEIN; GAMMA INTERFERON; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN P65; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NEOANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ALR LT MOUSE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DESTRUCTION; CHEMICAL REACTION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENIC STRESS; FEMALE; GENE EXPRESSION; IMMUNE MEDIATED INJURY; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR TRANSPORT; KINETICS; MITOCHONDRIAL GENETICS; MOUSE; MOUSE STRAIN; NITROTYROSYLATION; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; STRESS; WESTERN BLOTTING;

EID: 23244450300     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.2.1248     Document Type: Article

References (61)

1. Lenzen, S., J. Drinkgern, and M. Tiedge. 1996. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20: 463-466.
2. Tiedge, M., S. Lortz, J. Drinkgern, and S. Lenzen. 1997. Relation between antioxidant enzyme gene-expression and antioxidative defense status of insulin-producing cells. Diabetes 46: 1733-1742.
3. Graser, R. T., C. E. Mathews, E. H. Leiter, and D. V. Serreze. 1999. MHC characterization of ALR and ALS mice: respective similarities to the NOD and NON strains. Immunogenetics 49: 722-726.
4. Mathews, C. E., R. T. Graser, R. J. Bagley, J. W. Caldwell, R. Li, G. A. Churchill, D. V. Serreze, and E. H. Leiter. 2003. Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress. Immunogenetics 55: 491-496.
5. Mathews, C. E., E. H. Leiter, O. Spirina, Y. Bykhovskaya, A. Gusdon, S. Ringquist, and N. Fischel-Ghodsian. 2005. mt-Nd2 allele of the ALR/Lt mouse confers resistance against both chemically induced and autoimmune diabetes. Diabetologia 48: 261-267.
6. Ino, T., Y. Kawamoto, K. Sato, K. Nishikawa, A. Yamada, K. Ishibashi, and F. Sekiguchi. 1991. Selection of mouse strains showing high and low incidences of alloxan-induced diabetes. Jikken Dobutsu 40: 61-67.
7. Mathews, C. E., and E. H. Leiter. 1999. Constitutive differences in antioxidant defense status distinguish alloxan resistant (ALR/Lt) and alloxan susceptible (ALS/Lt) mice. Free Radic. Biol. Med. 27: 449-455.
8. Mathews, C. E., R. Graser, A. Savinov, D. Serreze, and E. H. Leiter. 2001. Unusual resistance of ALR/Lt β cells to autoimmune destruction: role for β cell expressed resistance determinants. Proc. Natl. Acad. Sci. USA 98: 235-240.
9. Wachlin, G., P. Augstein, D. Schroder, B. Kuttler, I. Kloting, P. Heinke, and S. Schmidt. 2003. IL-1β, IFN-γ and TNF-α increase vulnerability of pancreatic β cells to autoimmune destruction. J. Autoimmun. 20: 303-312.
10. Pakala, S. V., M. Chivetta, C. B. Kelly, and J. D. Katz. 1999. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α. J. Exp. Med. 189: 1053-1062.
11. Rabinovitch, A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diab. Metab. Rev. 14: 129-151.
12. Rabinovitch, A., W. L. Suarez Pinzon, K. Strynadka, J. R. Lakey, and R. V. Rajotte. 1996. Human pancreatic islet β-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J. Clin. Endocrinol. Metab. 81: 3197-3202.
13. Rabinovitch, A., W. L. Suarez, P. D. Thomas, K. Strynadka, and I. Simpson. 1992. Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation. Diabetologia 35: 409-413.
14. Heitmeier, M. R., A. L. Scarim, and J. A. Corbett. 1997. Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J. Biol. Chem. 272: 13697-13704.
15. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
16. Pryor, W. A., and G. L. Squadrito. 1995. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268(5 Pt. 1): L699-L722.
17. Squadrito, G. L., and W. A. Pryor. 1995. The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem. Biol. Interact. 96: 203.
18. Crow, J. P., and J. S. Beckman. 1995. Reactions between nitric oxide, superoxide, and peroxynitrite: footprints of peroxynitrite in vivo. Adv. Pharmacol. 34: 17-43.
19. Crow, J. P., and J. S. Beckman. 1995. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top Microbiol. Immunol. 196: 57-73.
20. Szabo, C. 1996. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6: 79-88.
21. Andersson, A. K., M. Flodstrom, and S. Sandler. 2001. Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase. Biochem. Biophys. Res. Commun. 281: 396-403.
22. -/-). Diabetes 49: 1116-1122.
23. Lakey, J. R., W. L. Suarez-Pinzon, K. Strynadka, G. S. Korbutt, R. V. Rajotte, J. G. Mabley, C. Szabo, and A. Rabinovitch. 2001. Peroxynitrite is a mediator of cytokine-induced destruction of human pancreatic islet β cells. Lab. Invest. 81: 1683-1692.
24. Dupraz, P., S. Cottet, F. Hamburger, W. Dolci, E. Felley-Bosco, and B. Thorens. 2000. Dominant negative MyD88 protein inhibits interleukin-1β/ interferon-γ-mediated induction of nuclear factor κB-dependent nitrite production and apoptosis in β cells. J. Biol. Chem. 275: 37672-37678.
25. Kwon, G., J. A. Corbett, and M. L. McDaniel. 1996. Interleukin I-induced fos and jun do not regulate inducible nitric oxide synthase in rat islets of Langerhans and RINm5F cells. Endocrinology 137: 825-830.
26. Keinanen, R., N. Vartiainen, and J. Koistinaho. 1999. Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene. Gene 234: 297-305.
27. Giannoukakis, N., W. A. Rudert, M. Trucco, and P. D. Robbins. 2000. Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J. Biol. Chem. 275: 36509-36513.
28. Todaro, M., F. Di Gaudio, M. Lavitrano, G. Stassi, and G. Papaccio. 2003. Islet β-cell apoptosis triggered in vivo by interleukin-1β is not related to the inducible nitric oxide synthase pathway: evidence for mitochondrial function impairment and lipoperoxidation. Endocrinology 144: 4264-4271.
29. Gotoh, M., T. Maki, T. Kiyoizumi, S. Satomi, and A. P. Monaco. 1985. An improved method for the isolation of mouse pancreatic islets. Transplantation 40: 437-438.
30. Mossmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
31. Sladowski, D., S. J. Steer, R. H. Clothier, and M. Balls. 1993. An improved MTT assay. J. Immunol. Methods 157: 203-207.
32. Demmano, G., E. Selegny, and J. C. Vincent. 1996. Experimental procedure for a hydrogen peroxide assay based on the peroxidase-oxidase reaction. Eur. J. Biochem. 238: 785-789.
33. Lenton, K. J., H. Therriault, and J. R. Wagner. 1999. Analysis of glutathione and glutathione disulfide in whole cells and mitochondria by postcolumn derivatization high-performance liquid chromatography with ortho-phthalaldehyde. Anal. Biochem. 274: 125-130.
34. 15N)nitrate in biological fluids. Anal. Biochem. 126: 131-138.
35. Hensley, K., M. L. Maidt, Q. N. Pye, C. A. Stewart, M. Wack, T. Tabatabaie, and R. A. Floyd. 1997. Quantitation of protein-bound 3-nitrotyrosine and 3,4-dihydroxyphenylalanine by high-performance liquid chromatography with electrochemical array detection. [Published erratum appears in 1998 Anal. Biochem. 256: 148.] Anal. Biochem. 251: 187-195.
36. Kamisaki, Y., K. Wada, K. Nakamoto, Y. Kishimoto, M. Kitano, and T. Itoh. 1996. Sensitive determination of nitrotyrosine in human plasma by isocratic high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 685: 343-347.
37. Suarez-Pinzon, W., C. Szabo, and A. Rabinovitch. 1997. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic-islet β-cells. Diabetes 46: 907-911.
38. Rabinovitch, A., and W. L. Suarez-Pinzon. 1998. Cytokines and their roles in pancreatic islet β cell destruction and insulin dependent diabetes mellitus. Biochem. Pharmacol. 55: 1139-1149.
39. Mathews, C. E., and E. H. Leiter. 1999. Resistance of ALR/Lt islets to free radical mediated diabetogenic stress is inherited as a dominant trait. Diabetes 48: 2189-2196.
40. Brunelli, L., J. P. Crow, and J. S. Beckman. 1995. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch. Biochem. Biophys. 316: 327-334.
41. 1 mice. Diabetes 37: 252-255.
42. 1 bone marrow chimeras. Diabetologia 33: 84-92.
43. 1 mice with bone marrow cells from NOD mice. J. Exp. Med. 167: 1801-1810.
44. Tabatabaie, T., A. Vasquez-Weldon, D. R. Moore, and Y. Kotake. 2003. Free radicals and the pathogenesis of type 1 diabetes: β-cell cytokine-mediated free radical generation via cyclooxygenase-2. Diabetes 52: 1994-1999.
45. Cardozo, A. K., H. Heimberg, Y. Heremans, R. Leeman, B. Kutlu, M. Kruhoffer, T. Orntoft, and D. L. Eizirik. 2001. A comprehensive analysis of cytokine-induced and nuclear factor κB-dependent genes in primary rat pancreatic β-cells. J. Biol. Chem. 276: 48879-48886.
46. Cardozo, A. K., M. Kruhoffer, R. Leeman, T. Orntoft, and D. L. Eizirik. 2001. Identification of novel cytokine-induced genes in pancreatic β-cells by high-density oligonucleotide arrays. Diabetes 50: 909-920.
47. Cardozo, A. K., P. Proost, C. Gysemans, M. C. Chen, C. Mathieu, and D. L. Eizirik. 2003. IL-1β and IFN-γ induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 46: 255-266.
48. Azevedo-Martins, A. K., S. Lortz, S. Lenzen, R. Curi, D. L. Eizirik, and M. Tiedge. 2003. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor κB activation in insulin-producing cells. Diabetes 52: 93-101.
49. Kutlu, B., A. K. Cardozo, M. I. Darville, M. Kruhoffer, N. Magnusson, T. Orntoft, and D. L. Eizirik. 2003. Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52: 2701-2719.
50. Guo, Z., K. Higuchi, and M. Mori. 2003. Spontaneous hypomorphic mutations in antioxidant enzymes of mice. Free Radic. Biol. Med. 35: 1645-1652.
51. Mathews, C. E., B. D. Dunn, M. O. Hannigan, C. K. Huang, and E. H. Leiter. 2002. Genetic control of neutrophil superoxide production in diabetes-resistant ALR/Lt mice. Free Radic. Biol. Med. 32: 744-751.
52. Birnboim, H. C., A. M. Lemay, D. K. Lam, R. Goldstein, and J. R. Webb. 2003. Cutting edge: MHC class II-restricted peptides containing the inflammation-associated marker 3-nitrotyrosine evade central tolerance and elicit a robust cell-mediated immune response. J. Immunol. 171: 528-532.
53. Poligone, B., D. J. Weaver, Jr., P. Sen, A. S. Baldwin, Jr., and R. Tisch. 2002. Elevated NF-κB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function. J. Immunol. 168: 188-196.
54. Sen, P., S. Bhattacharyya, M. Wallet, C. P. Wong, B. Poligone, M. Sen, A. S. Baldwin, Jr., and R. Tisch. 2003. NF-κB hyperactivation has differential effects on the APC function of nonobese diabetic mouse macrophages. J. Immunol. 170: 1770-1780.
55. Weaver, D. J., Jr., B. Poligone, T. Bui, U. M. Abdel-Motal, A. S. Baldwin, Jr., and R. Tisch. 2001. Dendritic cells from nonobese diabetic mice exhibit a defect in NF-κB regulation due to a hyperactive IκB kinase. J. Immunol. 167: 1461-1468.
56. Uchigata, Y., T. Okada, J. S. Gong, Y. Yamada, Y. Iwamoto, and M. Tanaka. 2002. A mitochondrial genotype associated with the development of autoimmune-related type 1 diabetes. Diabetes Care 25: 2106.
57. Turko, I. V., L. Li, K. S. Aulak, D. J. Stuehr, J. Y. Chang, and F. Murad. 2003. Protein tyrosine nitration in the mitochondria from diabetic mouse heart: implications to dysfunctional mitochondria in diabetes. J. Biol. Chem. 278: 33972-33977.
58. Riobo, N. A., E. Clementi, M. Melani, A. Boveris, E. Cadenas, S. Moncada, J., and J. Poderoso. 2001. Nitric oxide inhibits mitochondrial NADH:ubiquinone reductase activity through peroxynitrite formation. Biochem. J. 359(Pt. 1): 139-145.
59. Kuo, W. N., and J. M. Kocis. 2002. Nitration/S-nitrosation of proteins by preoxinitrite-treatment and subsequent modification by glutathione S-transferase and glutathione peroxidase. Mol. Cell Biochem. 233: 57-63.
60. Kuo, W. N., J. M. Kocis, and M. Mewar. 2002. Protein Denitration/ modification by glutathione S-transferase and glutathione peroxidase. J. Biochem. Mol. Biol. Biophys. 6: 143-146.
61. Brown, G. C., and V. Borutaite. 2004. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 1658: 44-49.